The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy
Open Access
- 14 November 2018
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 8 (4) , 37
Abstract
This study aims to investigate the effects of the three potassium channel genes KCNA1, KCNA2, and KCNV2 on increased susceptibility to epilepsy as well as on responsiveness to antiepileptic drugs (AEDs). The pharmacogenetic and case-control cohort (n = 595) consisted of 296 epileptic patients and 299 healthy individuals. Epileptic patients were recruited from the Pediatric Neurology clinic at the Queen Rania Al Abdullah Hospital (QRAH) in Amman, Jordan. A custom platform array search for genetic association in Jordanian-Arab epileptic patients was undertaken. The MassARRAY system (iPLEX GOLD) was used to genotype seven single nucleotide polymorphisms (SNPs) within three candidate genes (KCNA1, KCNA2, and KCNV2). Only one SNP in KCNA2, rs3887820, showed significant association with increased risk of susceptibility to generalized myoclonic seizure (p-value < 0.001). Notably, the rs112561866 polymorphism of the KCNA1 gene was non-polymorphic, but no significant association was found between the KCNA1 (rs2227910, rs112561866, and rs7974459) and KCNV2 (rs7029012, rs10967705, and rs10967728) polymorphisms and disease susceptibility or drug responsiveness among Jordanian patients. This study suggests that a significant association exists between the KCNA2 SNP rs3887820 and increased susceptibility to generalized myoclonic seizure. However, the present findings indicate that the KCNA1 and KCNV2 SNPs do not influence disease susceptibility and drug responsiveness in epileptic patients. Pharmacogenetic and case-control studies involving a multicenter and multiethnic approach are needed to confirm our results. To improve the efficacy and safety of epilepsy treatment, further studies are required to identify other genetic factors that contribute to susceptibility and treatment outcome.Keywords
Funding Information
- Jordan University of Science and Technology (RN: 407/2017)
This publication has 26 references indexed in Scilit:
- K+ channelepsy: progress in the neurobiology of potassium channels and epilepsyFrontiers in Cellular Neuroscience, 2013
- ABCC2 Polymorphisms and Haplotype are Associated with Drug Resistance in Chinese Epileptic PatientsCNS Neuroscience & Therapeutics, 2012
- Newly diagnosed epilepsy and pharmacogenomics research: A step in the right direction?Epilepsy & Behavior, 2011
- Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibilityProceedings of the National Academy of Sciences, 2011
- Seizures and Reduced Life Span in Mice Lacking the Potassium Channel Subunit Kv1.2, but Hypoexcitability and Enlarged Kv1 Currents in Auditory NeuronsJournal of Neurophysiology, 2007
- A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate SpecificityScience, 2007
- Idiopathic Generalized Epilepsies Recognized by the International League Against EpilepsyEpilepsia, 2005
- Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)Epilepsia, 2005
- Genetic mechanisms that underlie epilepsyNature Reviews Neuroscience, 2004
- A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsyBrain, 1999